‘Inactive’ drug ingredients are not always inactive, study finds – STAT
The label on a pill bottle lists the drug’s active and inactive ingredients, but new research concludes some “inactive” ingredients aren’t so inactive.
Related Articles
WHO’s top scientist learned a hard lesson about H5N1 two decades ago: Stopping it takes more than biology
Dairy farmers’ reluctance to report H5N1 infections among cows or allow testing of their workers is complicating the public health response to the bird flu.
Lawmakers unlikely to permanently extend telehealth flexibilities this year
Members of Congress appear likely to opt for a short-term extension of Medicare telehealth policies instead of permanent changes.
STAT’s Casey Ross and Bob Herman named 2024 Pulitzer Prize finalists
STAT’s Casey Ross and Bob Herman have been named 2024 Pulitzer Prize finalists. Read executive editor Rick Berke’s note to readers on the honor.
Endo Health ordered to pay more than $1.5 billion in opioid criminal case
Endo “was one of the worst actors in the opioid crisis” said Andrew Kolodny of the Opioid Policy Research Collaborative at Brandeis University.
Life science leaders on how to make drug development less expensive, slow, and risky
New ways of identifying and testing therapies, a more precise understanding of disease, and a renewed sense of urgency could help speed up drug development.
Young boy dies in trial for Pfizer Duchenne gene therapy
A boy with Duchenne muscular dystrophy died after receiving a Pfizer experimental gene therapy. The company is pausing its trial in older boys.
Young boy dies in trial for Pfizer Duchenne gene therapy
A boy with Duchenne muscular dystrophy died after receiving a Pfizer experimental gene therapy. The company is pausing its trial in older boys.
House panel eyes PBM reform to pay for telehealth extensions
A House proposal includes extension of more flexible rules for telehealth and hospital home-care programs. To pay for it, it seeks new limits on pharmacy…
High blood pressure in kids doubles their risk of cardiovascular disease, study finds, bringing a call for routine screening
“Imagine the vast majority of the pediatric population where they’re not even checking blood pressure,” says the author of a study that links chidren’s hypertension…
Statehouses are a hotbed of tobacco lobbying and legislation
Lobbying registrations tied to tobacco companies jumped over 10% from 2023 to 2024, and lobbyists are busy pushing and opposing laws in statehouses.